These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18268888)

  • 61. Linking miRNA regulation to BCR-ABL expression: the next dimension.
    Faber J; Gregory RI; Armstrong SA
    Cancer Cell; 2008 Jun; 13(6):467-9. PubMed ID: 18538729
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Major molecular response to imatinib in a patient with acute mixed lineage leukemia expressing a novel BCR/ABL transcript].
    Liu HX; Cao XY; Tong CR; Wu T; Wang T; Fan QZ; Wu P; Zhang X; Cai P; Zhu P
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):220-3. PubMed ID: 19552835
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Correlation of quantification of major bcr-abl mRNA between TMA (transcription mediated amplification) method and real-time quantitative PCR].
    Yagasaki F; Niwa T; Abe A; Ishikawa M; Kato C; Ogura K; Sasaki H; Kyo T; Jinnai I; Bessyo M; Miyamura K
    Rinsho Ketsueki; 2009 Jun; 50(6):481-7. PubMed ID: 19571508
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of Philadelphia-positive chronic myeloid leukemia with imatinib: importance of a stable molecular response.
    Palandri F; Iacobucci I; Soverini S; Castagnetti F; Poerio A; Testoni N; Alimena G; Breccia M; Rege-Cambrin G; Tiribelli M; Varaldo R; Abruzzese E; Martino B; Luciano L; Pane F; Saglio G; Martinelli G; Baccarani M; Rosti G
    Clin Cancer Res; 2009 Feb; 15(3):1059-63. PubMed ID: 19188180
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?
    Lichtman MA
    Oncologist; 2008 Jun; 13(6):645-54. PubMed ID: 18586919
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase?
    de Almeida Filho TP; Maia Filho PA; Barbosa MC; Dutra LLA; Castro MF; Duarte FB; Quixadá ATS; Lemes RPG
    Hematol Transfus Cell Ther; 2019; 41(2):114-118. PubMed ID: 31079657
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Screening for BCR-ABL1 in Patients with an Isolated Eosinophilia.
    Langabeer SE
    Clin Lab; 2016 Oct; 62(10):2073-2074. PubMed ID: 28164528
    [No Abstract]   [Full Text] [Related]  

  • 68. BCR::ABL1 transcripts and clinical outcome - interrogating the technique.
    Branford S
    Br J Haematol; 2022 Apr; 197(1):9-10. PubMed ID: 35112716
    [No Abstract]   [Full Text] [Related]  

  • 69. Skin, blood, nerve cells, and heritability. New lessons from neurofibromatosis type 1.
    Riccardi VM
    Arch Dermatol; 1995 Aug; 131(8):944. PubMed ID: 7632067
    [No Abstract]   [Full Text] [Related]  

  • 70. Coexistence of multiple myeloma and chronic myelogenous leukemia.
    Tanaka M; Tanaka K; Oizumi K
    Int J Hematol; 1999 Aug; 70(2):132-3. PubMed ID: 10497853
    [No Abstract]   [Full Text] [Related]  

  • 71. Bilateral proliferative retinopathy in chronic myelogenous leukemia.
    Huynh TH; Johnson MW; Hackel RE
    Retina; 2007 Jan; 27(1):124-5. PubMed ID: 17218931
    [No Abstract]   [Full Text] [Related]  

  • 72. [Analysis of the prevalence of leukemia in the populations of Kraków and Sandomierz in 1963-1966].
    Kwiatkowski A
    Pol Tyg Lek; 1969 Sep; 24(37):1402-4. PubMed ID: 5349476
    [No Abstract]   [Full Text] [Related]  

  • 73. Two cases of myelogenous leucaemia in Kapaukus.
    COUVEE LM
    Trop Geogr Med; 1958 Dec; 10(4):323-4. PubMed ID: 13635849
    [No Abstract]   [Full Text] [Related]  

  • 74. Distribution of BCR::ABL1 Transcripts in the Different Clinical Phases of Chronic Myeloid Leukemia: Effect on Hematological Parameters and Patient Survival.
    Romero-Morelos P; González-Yebra AL; Herrerías-García A; Ruíz-Velázquez FA; Bueno-Rosario LJ; González-Yebra B
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790196
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Frequencies of BCR::ABL1 Transcripts in Patients with Chronic Myeloid Leukemia: A Meta-Analysis.
    Romero-Morelos P; González-Yebra AL; Muñoz-López D; Lara-Lona E; González-Yebra B
    Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397221
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Prognostic and Predictive Study of BCR-ABL Expression Based on Characterization of Fusion Transcripts.
    Upadhyay V; Raval A; Shah K; Shah FD; Rawal R
    Indian J Clin Biochem; 2020 Jan; 35(1):88-94. PubMed ID: 32071500
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence of the BCR/ABL1 transcripts in Mexican patients with chronic myelogenous leukemia.
    Meza-Espinoza JP; Gutiérrez-Angulo M; Vázquez-Cárdenas A; Delgado-Lamas JL; Esparza-Flores MA; González-García JR
    Rev Invest Clin; 2007; 59(5):338-41. PubMed ID: 18268888
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):347-50. PubMed ID: 12941187
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Effect of co-expressing M-bcr/abl and m-bcr/abl fusion gene transcripts on the clinical features of patients with chronic myelogenous leukemia at diagnosis].
    Meng WT; Liu T; Li JJ; Shi Q; Yu J; Cui X; Wu Y; Xiang B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):97-100. PubMed ID: 16468653
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
    Mundhada S; Luthra R; Cano P
    BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.